185 related articles for article (PubMed ID: 32727970)
1. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
[TBL] [Abstract][Full Text] [Related]
2. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
Vera CA; Oróstica L; Gabler F; Ferreira A; Selman A; Vega M; Romero CA
Int J Oncol; 2017 Apr; 50(4):1261-1270. PubMed ID: 28260038
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles in phagocytosis of the early and late increases of cell surface calreticulin induced by oxaliplatin.
Matsusaka K; Azuma Y; Kaga Y; Uchida S; Takebayashi Y; Tsuyama T; Tada S
Biochem Biophys Rep; 2022 Mar; 29():101222. PubMed ID: 35146135
[TBL] [Abstract][Full Text] [Related]
4. Late-stage inhibition of autophagy enhances calreticulin surface exposure.
Li DD; Xie B; Wu XJ; Li JJ; Ding Y; Wen XZ; Zhang X; Zhu SG; Liu W; Zhang XS; Peng RQ
Oncotarget; 2016 Dec; 7(49):80842-80854. PubMed ID: 27825129
[TBL] [Abstract][Full Text] [Related]
5. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.
Yang Y; Li XJ; Chen Z; Zhu XX; Wang J; Zhang LB; Qiang L; Ma YJ; Li ZY; Guo QL; You QD
PLoS One; 2012; 7(12):e50811. PubMed ID: 23251389
[TBL] [Abstract][Full Text] [Related]
6. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.
Garg AD; Krysko DV; Verfaillie T; Kaczmarek A; Ferreira GB; Marysael T; Rubio N; Firczuk M; Mathieu C; Roebroek AJ; Annaert W; Golab J; de Witte P; Vandenabeele P; Agostinis P
EMBO J; 2012 Mar; 31(5):1062-79. PubMed ID: 22252128
[TBL] [Abstract][Full Text] [Related]
7. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.
Obeid M
J Immunol; 2008 Aug; 181(4):2533-43. PubMed ID: 18684944
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin regulated intrinsic apoptosis through mitochondria-dependent and independent pathways mediated by ER stress in arsenite exposed HT-22 cells.
Wang X; Liu X; Chen Y; Wang H; Zhang R; Zhang Q; Wei Y; Shi S; Li X
Chemosphere; 2020 Jul; 251():126466. PubMed ID: 32443253
[TBL] [Abstract][Full Text] [Related]
9. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.
Sen Santara S; Lee DJ; Crespo Â; Hu JJ; Walker C; Ma X; Zhang Y; Chowdhury S; Meza-Sosa KF; Lewandrowski M; Zhang H; Rowe M; McClelland A; Wu H; Junqueira C; Lieberman J
Nature; 2023 Apr; 616(7956):348-356. PubMed ID: 37020026
[TBL] [Abstract][Full Text] [Related]
10. Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease.
Kuang XL; Liu F; Chen H; Li Y; Liu Y; Xiao J; Shan G; Li M; Snider BJ; Qu J; Barger SW; Wu S
J Neurosci Res; 2014 Oct; 92(10):1319-29. PubMed ID: 24860980
[TBL] [Abstract][Full Text] [Related]
11. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
12. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
Panaretakis T; Joza N; Modjtahedi N; Tesniere A; Vitale I; Durchschlag M; Fimia GM; Kepp O; Piacentini M; Froehlich KU; van Endert P; Zitvogel L; Madeo F; Kroemer G
Cell Death Differ; 2008 Sep; 15(9):1499-509. PubMed ID: 18464797
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids Prevent Enterovirus 71 Capsid Protein VP1 Induced Calreticulin Surface Exposure by Alleviating Neuronal ER Stress.
Hu DD; Mai JN; He LY; Li PQ; Chen WX; Yan JJ; Zhu WD; Deng L; Wei D; Liu DH; Yang SD; Yao ZB
Neurotox Res; 2017 Feb; 31(2):204-217. PubMed ID: 27848175
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.
Sukkurwala AQ; Martins I; Wang Y; Schlemmer F; Ruckenstuhl C; Durchschlag M; Michaud M; Senovilla L; Sistigu A; Ma Y; Vacchelli E; Sulpice E; Gidrol X; Zitvogel L; Madeo F; Galluzzi L; Kepp O; Kroemer G
Cell Death Differ; 2014 Jan; 21(1):59-68. PubMed ID: 23787997
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of a soluble calnexin from human placenta.
Olsen DT; Peng L; Træholt SD; Duus K; Højrup P; Houen G
Protein Expr Purif; 2013 Nov; 92(1):105-11. PubMed ID: 24056258
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone-mediated apoptotic B16-F1 cells induce specific anti-tumor immune response.
Cao C; Han Y; Ren Y; Wang Y
Cell Mol Immunol; 2009 Dec; 6(6):469-75. PubMed ID: 20003823
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells.
Peters LR; Raghavan M
J Immunol; 2011 Jul; 187(2):919-31. PubMed ID: 21670312
[TBL] [Abstract][Full Text] [Related]
18. The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells.
Colangelo T; Polcaro G; Ziccardi P; Muccillo L; Galgani M; Pucci B; Milone MR; Budillon A; Santopaolo M; Mazzoccoli G; Matarese G; Sabatino L; Colantuoni V
Cell Death Dis; 2016 Feb; 7(2):e2108. PubMed ID: 26913599
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia.
Wemeau M; Kepp O; Tesnière A; Panaretakis T; Flament C; De Botton S; Zitvogel L; Kroemer G; Chaput N
Cell Death Dis; 2010 Dec; 1(12):e104. PubMed ID: 21368877
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin is a fine tuning molecule in epibrassinolide-induced apoptosis through activating endoplasmic reticulum stress in colon cancer cells.
Obakan-Yerlikaya P; Arisan ED; Coker-Gurkan A; Adacan K; Ozbey U; Somuncu B; Baran D; Palavan-Unsal N
Mol Carcinog; 2017 Jun; 56(6):1603-1619. PubMed ID: 28112451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
